The Children’s Tumor Foundation’s Young Investigator Award program received a boost this month when the Boston Children’s Hospital Neurofibromatosis Program decided to partner with CTF to help fund the 2017 Young Investigator Awards. Dr. David Miller of Boston Children’s Hospital directs the research initiative focused on MPNST, a malignant neurofibroma occurring in a small minority of NF1 patients that typically has a poor treatment outcome. In addition to the usual CTF sponsorship of the program, this partnership will offer specific funding for at least one meritorious YIA application that is focused on translating genomic information into medical treatments for MPNST.
Dr. Miller visited the CTF office in New York on Nov 22 and met with Annette Bakker, CTF’s President and Chief Scientific Officer, Salvatore La Rosa, Vice President of Research, and Dr. Jaishri Blakeley, director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP) to learn about the various initiatives the two organizations are conducting and to discuss partnership possibilities.
Seen in the picture are (l-r): Dr. Salvatore La Rosa, Dr. David Miller, Dr. Jaishri Blakeley, and Dr. Annette Bakker.
